PAG-led platform Gamot buys 70% in Chennai-based Anjan Drug
Posted by
www.biotecnika.org
PE major has joined hands with CX Partners, Samara Capital to invest
up to $500 m in Indian pharma companies. Gamot will be led by PAG as a
majority partner.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pag-led-platform-gamot-buys-70-in-anjan-drug/articleshow/78611069.cms
Subscribe to:
Post Comments (Atom)
August 18, 2021 at 2:36 AM
Extremely useful information which you have shared here. This is a great way to enhance knowledge for us, and also helpful for us. Thankful to you for sharing an article like this. Custom Led Signs Indoor
December 7, 2024 at 4:12 AM
The recent acquisition of a 70% stake in Chennai by the PAG-led platform Gamot showcases a significant move in the business landscape. Such developments highlight the importance of strategic partnerships and investment insights. For students analyzing similar cases in their academic work, seeking dissertation editing services can ensure their research is well-structured and insightful, reflecting the depth required in such intricate topics.
Post a Comment